Millennium Pharmacon International Tbk.
196
09 Oct 2026
PER
6,05
PBV
0,79
ROE
13,09%
Current Ratio
1,10
DER
521,62%
Berdasarkan data Trailing Twelve Months (TTM).
Klasifikasi
Info Umum
Tentang Perusahaan
PT Millennium Pharmacon International Tbk engages in the distribution and trading of prescription and non-prescription medicines, dietary supplements, and medical devices in Indonesia. The company distributes its products through drug stores, pharmacies, hospitals, supermarkets, and retail shops. As of December 31, 2021, it operated 33 branch offices in Java, Bali, Sumatera, Kalimantan, and Sulawesi Islands. The company was formerly known as PT NVPD Soedarpo Corporation Tbk and changed its name to PT Millennium Pharmacon International Tbk in February 1990. The company was founded in 1952 and is headquartered in Jakarta Selatan, Indonesia. PT Millennium Pharmacon International Tbk is a subsidiary of Pharmaniaga International Corporation Sdn. Bhd.
Rasio
Rasio Profitabilitas
Management Effectiveness
Rasio Liquiditas & Leverage
Rasio Aktivitas
Valuasi
Current Valuation
Per Share
Ukuran Perusahaan
Growth (TTM vs Tahun Terbaru)
Screening ala Graham
7 / 9Checklist ala kriteria defensive investor Benjamin Graham — bukan rekomendasi investasi, semata analisis kuantitatif berdasarkan data laporan keuangan terakhir.
Piotroski F-Score
6 / 9Altman Z-Score
2.72Model prediksi risiko kebangkrutan Edward Altman (1968) — Z > 2,99 Safe Zone, 1,81–2,99 Grey Zone, di bawah 1,81 Distress Zone.
Graham Valuation
Status Kuartal Terkini
Checklist fundamental berbasis TTM & laporan tahunan — label berwarna berarti kriteria terpenuhi.
Kinerja Dasar
Pertumbuhan Rata-rata (CAGR)
Solvabilitas
Likuiditas
Profitabilitas
Valuasi
Laba Kotor
Laba Bersih
Margin Laba Kotor
Margin Laba Operasi
Margin Laba Bersih
Imbal Hasil Aset (ROA)
Imbal Hasil Ekuitas (ROE)
Current Ratio
Quick Ratio
Debt to Equity Ratio (DER)
Perputaran Aset
Perputaran Persediaan
Perputaran Piutang
Tren historis per tahun buku berdasarkan laporan laba rugi & neraca yang tersedia. Batang berwarna merah menandakan nilai negatif.
| Item | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.298.328.976.778 | 4.109.810.339.016 | 3.916.863.878.530 | 3.363.517.807.834 | 3.200.833.096.416 | 2.988.848.566.331 | 2.643.630.000.000 | 2.726.760.000.000 | 2.376.180.000.000 |
| Cost of Revenue | 3.924.305.736.620 | 3.747.451.408.783 | 3.582.486.836.953 | 3.071.171.859.785 | 2.931.198.452.407 | 2.747.094.995.795 | 2.421.930.000.000 | 2.502.240.000.000 | 2.169.590.000.000 |
| Gross Profit | 374.023.240.158 | 362.358.930.233 | 334.377.041.577 | 292.345.948.049 | 269.634.644.009 | 241.753.570.536 | 221.692.000.000 | 224.512.000.000 | 206.595.000.000 |
| Operating Expenses | 255.713.258.533 | 248.821.889.062 | 237.943.332.998 | 186.948.370.891 | 191.737.683.772 | 185.776.866.619 | 167.916.000.000 | 2.662.150.000.000 | 2.313.480.000.000 |
| Operating Income | 118.309.981.625 | 113.537.041.171 | 96.433.708.579 | 105.397.577.158 | 77.896.960.237 | 55.976.703.917 | 53.775.173.056 | 64.604.074.931 | 62.698.476.996 |
| EBIT | 118.969.031.093 | 113.827.131.454 | 96.492.714.770 | 105.537.296.171 | 74.946.147.442 | — | 0 | 64.604.074.931 | 62.698.476.996 |
| Income Before Tax | 56.452.456.069 | 48.896.921.901 | 27.701.302.589 | 47.960.768.133 | 36.464.134.244 | 17.922.516.585 | 7.739.375.309 | 11.969.483.578 | 28.590.920.205 |
| Net Income | 41.285.985.941 | 38.468.911.988 | 16.928.878.936 | 33.087.528.526 | 24.464.054.875 | 9.571.235.584 | 2.804.331.066 | 7.880.007.292 | 19.444.262.069 |
| Basic EPS | 32,42 | 30,20 | 13,29 | 25,97 | 19,20 | 7,51 | — | — | — |
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total Aset | 1.960.719.855.135 | 1.771.856.829.401 | 1.639.682.291.798 | 1.401.504.764.117 |
| Aset Lancar | 1.718.941.631.851 | 1.563.794.217.415 | 1.447.652.336.556 | 1.258.958.579.876 |
| Kas | 62.842.729.716 | 53.472.920.923 | 58.899.533.733 | 25.668.366.059 |
| Piutang | 812.001.501.268 | 731.939.823.034 | 659.683.803.011 | 545.672.461.862 |
| Persediaan | 609.092.307.483 | 567.732.385.118 | 535.873.912.230 | 538.433.399.300 |
| Total Liabilitas | 1.645.316.608.203 | 1.489.359.909.392 | 1.361.968.904.232 | 1.142.594.625.772 |
| Liabilitas Lancar | 1.555.870.733.090 | 1.413.417.064.887 | 1.287.000.525.182 | 1.113.038.489.125 |
| Long Term Debt | 53.296.039.526 | 43.311.111.104 | 44.000.000.000 | 0 |
| Total Ekuitas | 315.424.481.215 | 282.515.493.501 | 277.717.214.244 | 258.910.138.345 |
| Working Capital | 163.070.898.761 | 150.377.152.528 | 160.651.811.374 | 145.920.090.751 |
| Item | TTM | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Kas dari Aktivitas Operasi | -125.895.091.824 | 88.096.095.852 | -125.450.792.643 | -91.653.278.370 | -109.946.538.729 | 0 |
| Kas dari Aktivitas Investasi | -33.738.274.209 | -49.974.968.827 | -13.920.657.362 | -5.520.523.024 | -14.608.868.888 | 0 |
| Kas dari Aktivitas Pembiayaan | 147.564.988.803 | -28.751.318.232 | 133.944.837.193 | 130.404.969.068 | 102.861.422.594 | 0 |
| Capital Expenditures | -51.153.079.601 | -49.099.750.320 | -14.158.567.273 | -21.519.515.943 | -14.678.788.087 | 0 |
| Arus Kas Bebas (FCF) | -177.048.171.425 | 38.996.345.532 | -139.609.359.916 | -113.172.794.313 | -124.625.326.816 | 0 |
| Dividen Dibayar | 0 | -2.540.762.728 | -3.185.000.000 | -2.548.000.000 | -1.274.000.000 | 0 |